STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.
종목 코드 STAA
회사 이름STAAR Surgical Co
상장일Feb 24, 1992
CEOMr. Stephen C. (Steve) Farrell, CPA
직원 수1157
유형Ordinary Share
회계 연도 종료Feb 24
주소1911 Walker Ave
도시MONROVIA
증권 거래소NASDAQ Global Market Consolidated
국가United States of America
우편 번호91016
전화16263037902
웹사이트https://www.staar.com/
종목 코드 STAA
상장일Feb 24, 1992
CEOMr. Stephen C. (Steve) Farrell, CPA
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음